Reply to de Vries HE, Van Oijen MGH, de Jong DJ. Safety of infliximab in inflammatory bowel disease needs to be debated. Clin Gastroenterol Hepatol 2009;7:603-604

Sarah Caspersen, Christian Mortensen, Lene Riis, Tine Jess, Flemming Bendtsen, Sarah Caspersen, Christian Mortensen, Lene Riis, Tine Jess, Flemming Bendtsen

Abstract

Udgivelsesdato: 2009-Nov
OriginalsprogEngelsk
TidsskriftClinical Gastroenterology and Hepatology
Vol/bind7
Udgave nummer11
Sider (fra-til)1257
ISSN1542-3565
DOI
StatusUdgivet - 2009

Citationsformater